The Enterprise Value as of December 2025 (TTM) for Ligand Pharmaceuticals Incorporated (LGND) is 3.50B

According to Ligand Pharmaceuticals Incorporated’s latest financial reports and current stock price. The company's current Enterprise Value is 3.50B. This represents a change of 50.60% compared to the average of 2.32B of the last 4 quarters.

Ligand Pharmaceuticals Incorporated (LGND) Historical Enterprise Value (quarterly & annually)

How has LGND Enterprise Value performed in the past?

The mean historical Enterprise Value of Ligand Pharmaceuticals Incorporated over the last ten years is 2.12B. The current 3.50B Enterprise Value has changed 16.38% with respect to the historical average. Over the past ten years (40 quarters), LGND's Enterprise Value was at its highest in in the September 2018 quarter at 6.46B. The Enterprise Value was at its lowest in in the March 2020 quarter at 907.54M.

Ligand Pharmaceuticals Incorporated (LGND) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ligand Pharmaceuticals Incorporated Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ligand Pharmaceuticals Incorporated (LGND) Average Enterprise Value

How has LGND Enterprise Value performed in the past?

The current Enterprise Value of Ligand Pharmaceuticals Incorporated (LGND) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ligand Pharmaceuticals Incorporated (LGND) Enterprise Value vs. Peers

How is LGND’s Enterprise Value compared to its peers?

Ligand Pharmaceuticals Incorporated’s Enterprise Value is less than Praxis Precision Medicines, Inc. (3.86B), less than Belite Bio, Inc (5.28B), less than Mirum Pharmaceuticals, Inc. (3.57B), less than ACADIA Pharmaceuticals Inc. (4.29B), less than ADMA Biologics, Inc. (4.78B), greater than Soleno Therapeutics, Inc. (2.59B), less than Viking Therapeutics, Inc. (4.26B), less than Crinetics Pharmaceuticals, Inc. (4.44B), greater than Dyne Therapeutics, Inc. (2.49B), less than NewAmsterdam Pharma Company N.V. (3.52B),

Build a custom stock screener for Ligand Pharmaceuticals Incorporated (LGND) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ligand Pharmaceuticals Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ligand Pharmaceuticals Incorporated (LGND) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ligand Pharmaceuticals Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.